MR-based Assessment of Therapy

MR-based Assessment of Therapy   

Thursday, Dec. 2, 4:30 – 6:00 PM

Speakers are addressing principles, applications and examples of dynamic contrast-enhanced MR imaging in clinical trials and oncologic imaging; metabolic and prognostic data available using MR spectroscopy and principles and applications of diffusion MR imaging.

Speaker Information:
  • Willi Kalender, PhD, director, Institute of Medical Physics, University of Erlangen in Germany; and
  • Edward Jackson, PhD, deputy department chair, imaging physics, MD Anderson Cancer Center in Houston.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.